Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC)
0.1.20 - Build CI United States of America flag

Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions

: EVMPD Substance Classification - TTL Representation

Draft as of 2024-03-04

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "evmpd-substance-classification"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"CodeSystem-cmc-ema-dummy.html\"><code>http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummy</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-1\">1</a></td><td>Chemical</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-17\">17</a></td><td>Mixture</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-2\">2</a></td><td>Nucleic Acid</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-3\">3</a></td><td>Polymer</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-4\">4</a></td><td>Protein - Other</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-5\">5</a></td><td>Protein - Vaccine</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-7\">7</a></td><td>Structurally Diverse Substance - Immunoglobulin</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-6\">6</a></td><td>Structurally Diverse Substance - Vaccine</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-10\">10</a></td><td>Structurally Diverse Substance - Allergen</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-11\">11</a></td><td>Structurally Diverse Substance - Cell therapy</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-9\">9</a></td><td>Structurally Diverse Substance - Herbal</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-12\">12</a></td><td>Structurally Diverse Substance - Other</td></tr><tr><td><a href=\"CodeSystem-cmc-ema-dummy.html#cmc-ema-dummy-8\">8</a></td><td>Structurally Diverse Substance - Blood derived</td></tr></table></li></ul></div>"
  ] ; # 
  fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ;
fhir:value [ fhir:v "brr" ]
  ] ) ; # 
  fhir:url [ fhir:v "http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/evmpd-substance-classification"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "0.1.20"] ; # 
  fhir:name [ fhir:v "EVMPDSubstanceClassification"] ; # 
  fhir:title [ fhir:v "EVMPD Substance Classification"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:experimental [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2024-03-04T02:24:01+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "HL7 International / Biomedical Research and Regulation"] ; # 
  fhir:contact ( [
fhir:name [ fhir:v "HL7 International / Biomedical Research and Regulation" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://www.hl7.org/Special/committees/rcrim" ]     ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "brr@lists.HL7.org" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "EudraVigilance eXtended Medicinal Product Dictionary (XEVMPD) substance classes"] ; # 
  fhir:jurisdiction ( [
    ( fhir:coding [
fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
fhir:code [ fhir:v "US" ] ;
fhir:display [ fhir:v "United States of America" ]     ] )
  ] ) ; # 
  fhir:compose [
    ( fhir:include [
fhir:system [ fhir:v "http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummy"^^xsd:anyURI ] ;
      ( fhir:concept [
fhir:code [ fhir:v "1" ] ;
fhir:display [ fhir:v "Chemical" ]       ] [
fhir:code [ fhir:v "17" ] ;
fhir:display [ fhir:v "Mixture" ]       ] [
fhir:code [ fhir:v "2" ] ;
fhir:display [ fhir:v "Nucleic Acid" ]       ] [
fhir:code [ fhir:v "3" ] ;
fhir:display [ fhir:v "Polymer" ]       ] [
fhir:code [ fhir:v "4" ] ;
fhir:display [ fhir:v "Protein - Other" ]       ] [
fhir:code [ fhir:v "5" ] ;
fhir:display [ fhir:v "Protein - Vaccine" ]       ] [
fhir:code [ fhir:v "7" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Immunoglobulin" ]       ] [
fhir:code [ fhir:v "6" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Vaccine" ]       ] [
fhir:code [ fhir:v "10" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Allergen" ]       ] [
fhir:code [ fhir:v "11" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Cell therapy" ]       ] [
fhir:code [ fhir:v "9" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Herbal" ]       ] [
fhir:code [ fhir:v "12" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Other" ]       ] [
fhir:code [ fhir:v "8" ] ;
fhir:display [ fhir:v "Structurally Diverse Substance - Blood derived" ]       ] )     ] )
  ] . #